Telomerase activity in cell lines and lymphoma originating from Bloom syndrome

被引:3
|
作者
Kaneko, H [1 ]
Morimoto, W [1 ]
Fukao, T [1 ]
Kasahara, K [1 ]
Kondo, N [1 ]
机构
[1] Gifu Univ, Sch Med, Dept Pediat, Gifu 5008705, Japan
关键词
Bloom syndrome; BLM; telomerase; telomere repeat length;
D O I
10.3109/10428190109099338
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bloom syndrome (BS) is characterized by premature aging and high predisposition to various types of cancer. BLM is the causative gene for BS. BLM functions as a DNA helicase in the direction of 3 ' to 5 ' and small subsets of telomeres colocalize with BLM protein. We investigated telomerase activity and telomere repeat length in the cells from BS patients. In Epstein-Barr-virus EBV) transformed lymphoblastoid cell lines and lymphoma cells from BS patients, telomerase activity was detected as in the control and compared. The metastatic tumor from BS patient, which had a 9-bp deletion of p53 DNA showed the strongest telomerase activity. Telomere repeat length in BS cells showed that there is no large difference compared with normal cells. Collectively, the results show that the BLM gene is not a major structural and regulatory factor in maintaining telomere repeat length and telomerase activity.
引用
收藏
页码:757 / 760
页数:4
相关论文
共 50 条
  • [41] Telomerase activity in human renal cell carcinoma
    Mehle, C
    Piatyszek, MA
    Ljungberg, B
    Shay, JW
    Roos, G
    ONCOGENE, 1996, 13 (01) : 161 - 166
  • [42] TRAP-silver staining, a highly sensitive assay for measuring telomerase activity in tumor tissue and cell lines
    Dalla Torre, CA
    Maciel, RMB
    Pinheiro, NA
    Andrade, JAD
    de Toledo, SRC
    Villa, LL
    Cerutti, JM
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2002, 35 (01) : 65 - 68
  • [43] Critical telomerase activity for uncontrolled cell growth
    Wesch, Neil L.
    Burlock, Laura J.
    Gooding, Robert J.
    PHYSICAL BIOLOGY, 2016, 13 (04)
  • [44] Telomerase activity in human renal cell carcinoma
    Sugimura, K
    Yoshida, N
    Hisatomi, H
    Nakatani, T
    Ikemoto, S
    BJU INTERNATIONAL, 1999, 83 (06) : 693 - 697
  • [45] Telomerase activity and cell proliferation index in cholesteatoma
    Lee, SH
    Jang, YH
    Tae, K
    Park, YW
    Kang, MJ
    Kim, KR
    Park, CW
    ACTA OTO-LARYNGOLOGICA, 2005, 125 (07) : 707 - 712
  • [46] Subtelomeric Demethylation Deregulated hTERT Expression, Telomerase Activity, and Telomere Length in Four Nasopharyngeal Carcinoma Cell Lines
    Zhang, Zi-Xiong
    Wang, Yan
    Tao, Ze-Zhang
    Chen, Shi-Ming
    Xiao, Bo-Kui
    Zhou, Tao
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2014, 29 (07) : 289 - 294
  • [47] β-Lapachone (LAPA) Decreases Cell Viability and Telomerase Activity in Leukemia Cells: Suppression of Telomerase Activity by LAPA
    Moon, Dong-Oh
    Kang, Chang-Hee
    Kim, Mun-Ock
    Jeon, You-Jin
    Lee, Jae-Dong
    Choi, Yung Hyun
    Kim, Gi-Young
    JOURNAL OF MEDICINAL FOOD, 2010, 13 (03) : 481 - 488
  • [48] Bloom Syndrome Complicated by Low-Grade Lymphoma and Non-small Cell Lung Cancer: A Case Report
    Gould, Nathan J.
    Holjak, Emma J. B.
    Barat, Jalal
    Tay, Keng Yeow
    Dar, A. Rashid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [49] Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma
    Hara, T
    Noma, T
    Yamashiro, Y
    Naito, K
    Nakazawa, A
    UROLOGICAL RESEARCH, 2001, 29 (01): : 1 - 6
  • [50] Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma
    Shervington, Amal
    Patel, Rahima
    Lu, Chen
    Cruickshanks, Nichola
    Lea, Robert
    Roberts, Gareth
    Dawson, Tim
    Shervington, Leroy
    BRAIN RESEARCH, 2007, 1134 (01) : 45 - 52